Internal Medicine, Endocrinology, Diabetes, & Metabolism · Baytown, TX
NPI
1750347217
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
4002 Garth Rd Ste 120
Baytown, TX, 77521
Phone (281) 628-7240
Groups this clinician bills Medicare through
Medicare paid, 2024
$101K
1,593 services
Medicare patients, 2024
418
Average age 73
Drug cost, 2024
$3.9M
8,433 prescriptions
Company payments, 2025
$21K
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Manisha Chandalia was code 99214 (office e&m - established), 826 times for 362 patients. In total Manisha Chandalia billed 1,593 services in 11 codes, and Medicare paid $101K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-10-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 826 | 362 | $91.70 | $76K |
| 83036 Blood Count | Office | 468 | 233 | $9.30 | $4,352 |
| 95251 Test - Miscellaneous | Office | 171 | 65 | $25.25 | $4,318 |
| 99204 Office E&M - New | Office | 89 | 89 | $121.02 | $11K |
| 99205 Office E&M - New | Office | 15 | 15 | $168.56 | $2,528 |
| 99215 Office E&M - Established | Office | 15 | 15 | $139.29 | $2,089 |
By year: 2022 $95K for 1,528 services; 2023 $98K for 1,499 services; 2024 $101K for 1,593 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 468 | 233 | $9.30 | $4,352 |
Medicare prescription drug claims, 2024
In 2024, the drug Manisha Chandalia prescribed most often to Medicare patients was Pioglitazone Hcl, with 861 prescriptions and refills. In total Manisha Chandalia wrote 8,433 Medicare prescriptions that cost $3.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pioglitazone Hcl Generic | 861 | 2,129 | 284 | $10K |
| Jardiance Empagliflozin | 698 | 1,181 | 186 | $659K |
| Ozempic Semaglutide | 622 | 881 | 147 | $825K |
| Levothyroxine Sodium Generic | 598 | 1,733 | 203 | $7,008 |
| Metformin Hcl Er Metformin Hcl | 573 | 1,561 | 206 | $6,442 |
| Glipizide Er Glipizide | 440 | 1,191 | 156 | $8,173 |
| Mounjaro Tirzepatide | 433 | 513 | 95 | $532K |
| Farxiga Dapagliflozin Propanediol | 391 | 690 | 88 | $371K |
| Metformin Hcl Generic | 256 | 681 | 83 | $1,864 |
| Rosuvastatin Calcium Generic | 236 | 604 | 73 | $3,589 |
| Soliqua 100-33 Insulin Glargine/Lixisenatide | 210 | 296 | 58 | $235K |
| Glimepiride Generic | 166 | 447 | 53 | $1,723 |
| Trulicity Dulaglutide | 163 | 248 | 45 | $233K |
| Tresiba Flextouch U-100 Insulin Degludec | 156 | 230 | 42 | $104K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 130 | 361 | 60 | $12K |
Brand drugs: 4,158 claims; generic drugs: 3,931 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Manisha Chandalia $21K ($21K in general payments such as food, travel and fees) from 27 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $11K.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $11K |
| Lilly USA, LLC LLY | 13 | $5,896 |
| Novo Nordisk Inc NVO | 7 | $3,455 |
| Madrigal Pharmaceuticals MDGL | 3 | $286 |
| Insulet Corporation PODD | 9 | $233 |
| Kyowa Kirin, Inc. 4151.T | 2 | $119 |
| Radius Health, Inc. | 4 | $92.75 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $89.67 |
| Amgen Inc. AMGN | 4 | $85.69 |
| Tandem Diabetes Care, Inc. TNDM | 3 | $56.7 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.